Advertisement
Skip to Content

Merck & Co Inc MRK Stock Quote

| Rating as of

NYSE: MRK

Last close prices updated as of Jan 27, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 105.38
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Large Blend
  • Day Range 105.11  –  106.68
  • Year Range 72.88  –  115.49
  • Market Cap 267.1800 Bil
  • Volume / Avg 7.8 Mil /  9.4 Mil
  • Price / Sales 4.54
  • Price / Book 6.01
  • Forward Div Yield 2.66%
  • Trailing Div Yield 2.66%

Morningstar‘s Stock Analysis MRK

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Merck Looks Well Positioned for Growth Over the Next Five Years, Led by Cancer Drug Keytruda

Damien Conover Sector Director

Business Strategy and Outlook

| Damien Conover |

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the Organon business in June 2021, the remaining portfolio at Merck holds a higher percentage of drugs with strong patent protection. On the pipeline front, after several years of only moderate research and development productivity, Merck's drug development strategy is yielding important new drugs.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MRK

Company Profile MRK

Business Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Contact
2000 Galloping Hill Road
Kenilworth, NJ, 07033
Industry Drug Manufacturers - General
Employees 68,000

Related Articles MRK

FAQs for Merck & Co Inc Stock

Yes. MRK has a forward dividend yield of 2.66%. See MRK’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MRK’s market cap is 267.18 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MRK’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MRK’s price/sales is 4.54.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

MRK’s price/forward earnings is 14.56.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

MRK’s price/book is 6.01.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See MRK’s valuation ratios compared to the Market Index.

MRK’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MRK’s historical performance against its industry peers and the overall market.